Cargando…

Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women

BACKGROUND: Studies investigating breast cancer polygenic risk score (PRS) in Chinese women are scarce. The objectives of this study were to develop and validate PRSs that could be used to stratify risk for overall and subtype-specific breast cancer in Chinese women, and to evaluate the performance...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Can, Xu, Bin, Hao, Yu, Yang, Daowen, Song, Huan, Li, Jiayuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991589/
https://www.ncbi.nlm.nih.gov/pubmed/35395775
http://dx.doi.org/10.1186/s12885-022-09425-3
_version_ 1784683600844685312
author Hou, Can
Xu, Bin
Hao, Yu
Yang, Daowen
Song, Huan
Li, Jiayuan
author_facet Hou, Can
Xu, Bin
Hao, Yu
Yang, Daowen
Song, Huan
Li, Jiayuan
author_sort Hou, Can
collection PubMed
description BACKGROUND: Studies investigating breast cancer polygenic risk score (PRS) in Chinese women are scarce. The objectives of this study were to develop and validate PRSs that could be used to stratify risk for overall and subtype-specific breast cancer in Chinese women, and to evaluate the performance of a newly proposed Artificial Neural Network (ANN) based approach for PRS construction. METHODS: The PRSs were constructed using the dataset from a genome-wide association study (GWAS) and validated in an independent case-control study. Three approaches, including repeated logistic regression (RLR), logistic ridge regression (LRR) and ANN based approach, were used to build the PRSs for overall and subtype-specific breast cancer based on 24 selected single nucleotide polymorphisms (SNPs). Predictive performance and calibration of the PRSs were evaluated unadjusted and adjusted for Gail-2 model 5-year risk or classical breast cancer risk factors. RESULTS: The primary PRS(ANN) and PRS(LRR) both showed modest predictive ability for overall breast cancer (odds ratio per interquartile range increase of the PRS in controls [IQ-OR] 1.76 vs 1.58; area under the receiver operator characteristic curve [AUC] 0.601 vs 0.598) and remained to be predictive after adjustment. Although estrogen receptor negative (ER(−)) breast cancer was poorly predicted by the primary PRSs, the ER(−) PRSs trained solely on ER(−) breast cancer cases saw a substantial improvement in predictions of ER(−) breast cancer. CONCLUSIONS: The 24 SNPs based PRSs can provide additional risk information to help breast cancer risk stratification in the general population of China. The newly proposed ANN approach for PRS construction has potential to replace the traditional approaches, but more studies are needed to validate and investigate its performance. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09425-3.
format Online
Article
Text
id pubmed-8991589
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89915892022-04-09 Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women Hou, Can Xu, Bin Hao, Yu Yang, Daowen Song, Huan Li, Jiayuan BMC Cancer Research BACKGROUND: Studies investigating breast cancer polygenic risk score (PRS) in Chinese women are scarce. The objectives of this study were to develop and validate PRSs that could be used to stratify risk for overall and subtype-specific breast cancer in Chinese women, and to evaluate the performance of a newly proposed Artificial Neural Network (ANN) based approach for PRS construction. METHODS: The PRSs were constructed using the dataset from a genome-wide association study (GWAS) and validated in an independent case-control study. Three approaches, including repeated logistic regression (RLR), logistic ridge regression (LRR) and ANN based approach, were used to build the PRSs for overall and subtype-specific breast cancer based on 24 selected single nucleotide polymorphisms (SNPs). Predictive performance and calibration of the PRSs were evaluated unadjusted and adjusted for Gail-2 model 5-year risk or classical breast cancer risk factors. RESULTS: The primary PRS(ANN) and PRS(LRR) both showed modest predictive ability for overall breast cancer (odds ratio per interquartile range increase of the PRS in controls [IQ-OR] 1.76 vs 1.58; area under the receiver operator characteristic curve [AUC] 0.601 vs 0.598) and remained to be predictive after adjustment. Although estrogen receptor negative (ER(−)) breast cancer was poorly predicted by the primary PRSs, the ER(−) PRSs trained solely on ER(−) breast cancer cases saw a substantial improvement in predictions of ER(−) breast cancer. CONCLUSIONS: The 24 SNPs based PRSs can provide additional risk information to help breast cancer risk stratification in the general population of China. The newly proposed ANN approach for PRS construction has potential to replace the traditional approaches, but more studies are needed to validate and investigate its performance. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09425-3. BioMed Central 2022-04-08 /pmc/articles/PMC8991589/ /pubmed/35395775 http://dx.doi.org/10.1186/s12885-022-09425-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hou, Can
Xu, Bin
Hao, Yu
Yang, Daowen
Song, Huan
Li, Jiayuan
Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women
title Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women
title_full Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women
title_fullStr Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women
title_full_unstemmed Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women
title_short Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women
title_sort development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in chinese women
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991589/
https://www.ncbi.nlm.nih.gov/pubmed/35395775
http://dx.doi.org/10.1186/s12885-022-09425-3
work_keys_str_mv AT houcan developmentandvalidationofpolygenicriskscoresforpredictionofbreastcancerandbreastcancersubtypesinchinesewomen
AT xubin developmentandvalidationofpolygenicriskscoresforpredictionofbreastcancerandbreastcancersubtypesinchinesewomen
AT haoyu developmentandvalidationofpolygenicriskscoresforpredictionofbreastcancerandbreastcancersubtypesinchinesewomen
AT yangdaowen developmentandvalidationofpolygenicriskscoresforpredictionofbreastcancerandbreastcancersubtypesinchinesewomen
AT songhuan developmentandvalidationofpolygenicriskscoresforpredictionofbreastcancerandbreastcancersubtypesinchinesewomen
AT lijiayuan developmentandvalidationofpolygenicriskscoresforpredictionofbreastcancerandbreastcancersubtypesinchinesewomen